TRX103

Treatment Description

TRX103 is an off-the-shelf allogeneic T-cell therapy that may help to prevent graft versus host disease in patients who receive bone marrow transplants.

Participating Centers

There are 3 centers running trials with this treatment. Enter a location below to find the closest center.